| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
ZURICH—To get a clear picture of the complexity of a given proteome, researchers have to be confident they are seeing all the participating proteins and peptides. Unfortunately, different isolation methods are biased toward different proteomic subpopulations. With this in mind, researchers at the Swiss Federal Institute of Technology and Seattle's Institute for Systems Biology performed a systematic analysis of three phosphoproteomic isolation methods to determine how much the three methods overlap.
 
As they report in Nature Methods, the researchers used phosphoramidate chemistry, immobilized metal affinity chromatography, and titanium oxide separation to isolate phosphopeptides from a trypsinized Drosophila cell extract.
 
Following the isolations, the researchers used LC-MS to compare protein patterns, finding modest overlap—about one-third—between the three isolation methods. They then used LC-MS/MS to identify specific peptides and found that the ~33% overlap was consistent at the sequence level.
 
The researchers were unable to make a definitive statement regarding the three methods because a "gold standard" complete phosphoproteome does not exist. However, they noted their results implied "that none of the methods by itself is currently able to comprehensively analyze a phosphoproteome."

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Reliable fluid biomarkers strategies for clinical neuroscience research

Reliable fluid biomarkers strategies for clinical neuroscience research

Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
A group of blue capsules is scattered on a bright yellow surface, with one capsule opened to reveal white powder inside.

Understanding drug impurities: types, sources, and analytical strategies

Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Laboratorian with a white coat and blue gloves pipettes green liquid into a beaker with multicolored liquids in beakers and tubes in the blue-tinged, sterile laboratory background.

Discovering cutting-edge nitrosamine analysis in pharmaceuticals

New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue